Pharmanet Logo
|
  • Contact Us
  • |
  • RFP
  • | 
  • Media Center
  • |
  • Study Participants
  • |
  • Investigators
  • |
  • Français
    • Overview
    • History
    • Leadership Team
    • Executive Committee
    • Corporate Responsibility
    • Overview
    • Phase I-IIa
      • First-in-Man
        • Diverse Experience
        • Modern Facilities
        • Project Management
        • Rapid Recruitment
      • Proof-of-Concept
      • Bioavailability / Bioequivalence / Biosimilars
      • Drug Drug Interaction
      • QT/TQT Capabilities
      • Special Populations
    • Bioanalytical
      • Non-GLP Analysis
      • Method Development & Validation
      • Biomarkers
      • Large Molecule Analysis
      • Clinical Lab
      • Assay List
      • Instrumentation
    • Phase IIb-III
      • Biostatistics and Statistical Programming
      • Clinical Monitoring
      • Data Management
      • Feasibility Studies
      • Global Safety and Pharmacovigilance
      • Interactive Response Technologies
      • Investigator Recruitment and Site Management
      • Medical and Scientific Affairs
      • Medical Writing
      • Project Management
      • Patient Recruitment Services
        • Program Branding and Communications
        • Advertising and Promotion
        • Referral Network Management
      • Rater Training
    • Phase IV
      • Observational Research and Patient Registries
      • Interventional IIIB/IV Studies
      • Health Economics and Outcomes Research
      • Risk Management and Epidemiology
    • Quality Assurance
    • Consulting
      • 505(b)(2)
      • Biostatistics
      • Business Plan Services
      • Chemistry, Manufacturing, and Controls (CMC)
      • Clinical and Product Development
      • Global Safety and Pharmacovigilance
      • Pharmacokinetics and Pharmacodynamics (PK/PD)
      • Regulatory Services
    • Functional Service Providers
    • Staffing
    • Therapeutic Overview
    • Clinical Development Expertise
      • Biosimilars
      • Generics
      • Pediatrics
      • Small Molecule Therapeutics
    • Therapeutic Indications
      • Cardiovascular
      • Infectious Diseases/Vaccines
      • Neuroscience
      • Oncology
      • Pain
    • Overview
    • Asia Pacific
    • Europe
    • Latin America
    • North America
    • Overview
    • Articles
    • Brochures
    • Case Studies
    • Fact Sheets
    • PharmaNet Publications
    • Posters
    • Presentations
    • Videos/Podcasts/Webinars
    • White Papers
    • Overview
    • FAQ
    • Job Opportunities
    • Training Programs
    • Flexible Staffing
Print
this page
Email to
a Friend
Overview
Articles
Brochures
Case Studies
Fact Sheets
PharmaNet Publications
Posters
Presentations
Videos/Podcasts/Webinars
White Papers

Posters

Define .xml Generator: A Metadata Driven Integrated Application Approach (981.54 KB)
Development of Validation of a DBS Assay for the Determination of Midazolam in Human Whole Blood by LC/MS/MS (2.18 MB)
Fast PK and Semi-Quantitative Analysis of Metabolites (1.63 MB)
Method Development for the Determination of Dienogest (1.35 MB)
Method Development for the Determination of Buprenorphine (532.15 KB)
Method Development for the Determination of Oxycodone in a Human DBS Sample using LC/MS/MS (1.57 MB)
Overcoming the Limitations of LC-MS/MS in the Quantitative Analysis of Free Testosterone: A Case for NCI GC-MS/MS (718.84 KB)
Quantitation of an Adsorption-Prone Compound (913.33 KB)
Reproducibility of Exemestane Assay (1.58 MB)
Robust Determination of Quaternary Ammonium Compound Scopolamine N-Butyl (1.47 MB)
Tissue Analysis of LCMSMS for Drug Distribution Studies (1.56 MB)
Validated LC-MS-MS Method for Capecitabine (962.46 KB)

  • 504 Carnegie Center, Princeton, NJ 08540 USA
  • |
  • Phone: +1-609-951-6800
  • |
  • Email: pni@pharmanet-i3.com
  • |
  • Site Map
  • |
  • Privacy Policy
  • |
  • Terms & Conditions